Literature DB >> 25921139

Aberrant expression of pim-3 promotes proliferation and migration of ovarian cancer cells.

Hao Zhuang1, Man-Yin Zhao, Kai-Wen Hei, Bai-Cai Yang, Li Sun, Xue Du, Yong-Mei Li.   

Abstract

Pim kinase-3(Pim-3), a member of serine/threonine protein kinases, has been implicated in multiple human cancers and involved in Myc-induced tumorigenesis. However, little is known regarding its expression and biological function in human ovarian cancer. In this study we showed that the clinical significance and biological functions of Pim-3 in ovarian cancer and found that higher Pim-3 mRNA level are detected in ovarian cancer tissues than those in normal ovarian tissues. There are significant correlations between higher Pim-3 expression levels with the FIGO stage, histopathological subtypes, and distant metastasis in ovarian cancer patients. Lentivirus-mediated gene overexpression of Pim-3 significantly promotes the proliferation and migration of SKOV3 cell lines. Furthermore, MACC1 and Pim-3 expression were significantly correlated in human ovarian cancer cells, and overexpression of Pim-3 in ovary cancer cells increased MACC1 mRNA and protein expression. The data indicate that Pim-3 acts as a putative oncogene in ovary cancer and could be a viable diagnostic and therapeutic target for ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25921139     DOI: 10.7314/apjcp.2015.16.8.3325

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.

Authors:  Jing Liu; Xinyu Qu; Liwei Shao; Yuan Hu; Xin Yu; Peixiang Lan; Qie Guo; Qiuju Han; Jian Zhang; Cai Zhang
Journal:  Cancer Biol Ther       Date:  2018-01-25       Impact factor: 4.742

2.  Expression of Pim-3 in colorectal cancer and its relationship with prognosis.

Authors:  Zhongguo Zhou; Rongxin Zhang; Ruojing Wang; Yaojun Zhang; Li Xu; Jinbin Chen; Jie Zhang; Zhongxi Huang; Minshan Chen; Zhizhong Pan
Journal:  Tumour Biol       Date:  2016-01-14

3.  Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC.

Authors:  Gillian Moore; Clara Lightner; Samira Elbai; Lauren Brady; Siobhan Nicholson; Ronan Ryan; Katie E O'Sullivan; Kenneth J O'Byrne; Carmen Blanco-Aparicio; Sinead Cuffe; Michael O'Neill; Susan Heavey; Stephen P Finn; Kathy Gately
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

Review 4.  PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer.

Authors:  Aziz Ur Rehman Aziz; Sumbal Farid; Kairong Qin; Hanqin Wang; Bo Liu
Journal:  Biomolecules       Date:  2018-02-04

5.  Glycine decarboxylase induces autophagy and is downregulated by miRNA-30d-5p in hepatocellular carcinoma.

Authors:  Hao Zhuang; Fei Wu; Wen Wei; Yamei Dang; Baicai Yang; Xuda Ma; Feng Han; Yongmei Li
Journal:  Cell Death Dis       Date:  2019-02-25       Impact factor: 8.469

6.  CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.

Authors:  Raoud Marayati; Laura L Stafman; Adele P Williams; Laura V Bownes; Colin H Quinn; Hooper R Markert; Juliet L Easlick; Jerry E Stewart; David K Crossman; Elizabeth Mroczek-Musulman; Elizabeth A Beierle
Journal:  Cancer Gene Ther       Date:  2021-04-16       Impact factor: 5.854

Review 7.  The Role of PIM Kinases in Pediatric Solid Tumors.

Authors:  Janet Rae Julson; Raoud Marayati; Elizabeth Ann Beierle; Laura Lee Stafman
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

8.  Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients.

Authors:  Rong-Xin Zhang; Zhong-Guo Zhou; Shi-Xun Lu; Zhen-Hai Lu; De-Sen Wan; Zhi-Zhong Pan; Xiao-Jun Wu; Gong Chen
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.